Sheaff Brock Investment Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36,000	Closed	-$5.49K	–	503
2023 Q2	$5.49K	Hold	36,000	–	–	﹤0.01%	490
2023 Q1	$5.17K	Buy	+36,000	New	+$5.76K	﹤0.01%	514

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Sheaff Brock Investment Advisors's HGEN Position: Q3 2023 in Review

Sheaff Brock Investment Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 36,000 shares — an estimated $5.49K sold.

Sheaff Brock Investment Advisors first reported a position in HGEN in Q1 2023 and held it in 2 quarters. The position peaked at $5.49K in Q2 2023. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Sheaff Brock Investment Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 36,000 HUMANIGEN, INC. shares in Q3 2023, an estimated $5.49K.
Sheaff Brock Investment Advisors first reported a position in HUMANIGEN, INC. in Q1 2023 and held it in 2 quarters.
Sheaff Brock Investment Advisors's HUMANIGEN, INC. position peaked at $5.49K in Q2 2023.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.